摘要:
To provide a therapeutic agent for fundamentally preventing, treating or ameliorating dermatosis, more preferably, non-infectious dermatosis, still more preferably, psoriasis or atopic dermatitis. A therapeutic agent for prevention, treatment or amelioration of dermatosis excluding itching comprising a glycerol derivative represented by the formula (I): wherein A is a group represented by the formula: or single bond; R 1 is a group represented by the formula: wherein R 2 is a methoxyphenyl group or methyl group, X is an atom or atomic group which may become an anion or a group represented by the formula: or a pharmacologically acceptable salt thereof as an active ingredient.
摘要翻译:提供一种用于从根本上预防,治疗或改善皮肤病的治疗剂,更优选非感染性皮肤病,还更优选地是牛皮癣或特应性皮炎。 一种预防,治疗或改善除瘙痒的皮肤病的治疗剂,其包含由式(I)表示的甘油衍生物:其中A为下式所示的基团:CHEM>或单键; R 1是由下式表示的基团:其中R 2是甲氧基苯基或甲基,X是可以成为阴离子的原子或原子团或由下式表示的基团:CHEM >或其药理学上可接受的盐作为活性成分。
摘要:
A triazolo-1,4-di-azepine compound of the below given formula and a pharmacologically acceptable salt thereof are disclosed and useful in the pharmaceutical field, especially to allergic diseases.
in which R1 and R2 are hydrogen or an alkyl, R3 is hydrogen or a halogen, R4 is hydrogen or an alkyl, X is -OCO-, -NHCO-, -CO- or others and Y is a cycloalkyl, a cycloalkylalkyl, an alkynyl or others. with the proviso that when R₁ is hydrogen then R₂ cannot be methyl.
摘要:
A new diphenyl-methane derivative is useful to inhibit agglomeration of blood and is defined by the formula, including a diphenylethylene derivative and a benzophenone oxime ether derivative.
in which R1 and R2 each are hydrogen, hydroxyl or a lower alkoxy, U is = CXY or = N-O-W, X is hydrogen, cyano or -COR6, R6 being hydroxyl or an amino, Y is -R10-COOR3, R3 being hydrogen or a lower alkoxy, R10 being an alkylene having 1 to 3 carbon atoms, straight or branched, -CO-NR4R5, R4 and R5 each being hydrogen, a lower alkyl or a lower arylalkyl, -CH2-NHS02-C6H5 or -C(R8)-= NR7, R7 being a lower alkoxy or an aryl, R8 is -VR9, V being oxygen, sulfur or nitrogen, R9 being an alkyl or an aryl, W is -CH2-CO-CH2-COOR13, R13 being hydrogen or a lower alkyl, -CH2-C(=NOR14)-CH2-COOR15, R15 being hydrogen or a lower alkyl, R14 being a lower alkyl, -CH(CN)-(CH2)q-COOR16, R16 being hydrogen or a lower alkyl, q being an integer of 1 to 3, or -(CH2)p-Z, Z being -SH, -SCN or a monovalent group derived from a five- or six-membered ring which may be substituted by a ring having one or more sulfur atoms in the ring, p being 1 or 2.
A pharmaceutical composition containing compounds of formula (XX) or their pharmaceutically acceptable salts as active ingredients, and the use of compounds of formula (XX) or their pharmaceutically acceptable salts in the preparation of a medicament for treatment of diseases caused by blood stream disorders are also disclosed.
摘要翻译:二苯基甲烷衍生物。 式(I)的化合物是新的(其中R 1和R 2各自为H,OH或低级烷氧基; U = -CXY或= NOW; X = H,CN或-COR 6; R 6 = OH或NH 2; Y = COOR3,-CONR4R5,-CH2NHSO2-C6H5或-C(R8)= NR7; R3 = H或低级烷氧基; R10 =选择性支链的1-3C亚烷基; R4和R5各自为H,低级烷基或低级芳基烷基; R7 = 低级烷氧基或芳基; R8 = -VR9; V = O,S或N; R9 =烷基或芳基; W = -CH2-CO-CH2-COOR13,-CH2-C(= NOR14)-CH2-COOR15,-CH (CN) - (CH 2)q -COOR 16或 - (CH 2)pZ; R 13 = H或低级烷基; R 14 =低级烷基; R 15 = H或低级烷基; R 16 = H或低级烷基; q = = -SH,-SCN或衍生自5-或6-元环选择性的单价gp,通过环中具有1个或更多个S的环; p = 1或2。
摘要:
A glycerin derivative having the following formula (I) or (I') and a pharmacologically acceptable salt thereof are useful to treat diseases caused by the platelet activating factor.
摘要翻译:具有下式(I)或(I min)的甘油衍生物及其药理学上可接受的盐可用于治疗血小板活化因子引起的疾病。 r
摘要:
A new diphenyl-methane derivative is useful to inhibit agglomeration of blood and is defined by the formula, including a diphenylethylene derivative and a benzophenone oxime ether derivative. in which R1 and R2 each are hydrogen, hydroxyl or a lower alkoxy, W is -CH2-CO-CH2-COOR13, R13 being hydrogen or a lower alkyl, -CH2-C(=NOR14)-CH2-COOR15, R15 being hydrogen or a lower alkyl, R14 being a lower alkyl, -CH(CN)-(CH2)q-COOR16, R16 being hydrogen or a lower alkyl, q being an integer of 1 to 3, or -(CH2)p-Z, Z being -SH, -SCN or a monovalent group derived from a five- or six-membered ring which may be substituted by a ring having one or more sulfur atoms in the ring, p being 1 or 2. A pharmaceutical composition containing compounds of formula (I) or their pharmaceutically acceptable salts as active ingredients, and the use of compounds of formula (I) or their pharmaceutically acceptable salts in the preparation of a medicament for treatment of diseases caused by blood stream disorders are also disclosed.